The data from our and other groups have confirmed that IFIT2 can serve as an important tumor suppressor gene, and decreased expression of IFIT2 significantly associated with cancer progression and poor prognosis of the patients [10, 12, 15]. The gene discussed is IFIT2; the disease is cancer.